Study S001715

[68Ga]Ga-HBED-CC-PEG6-Exendin-4 PET/CT Imaging in the Diagnosis of Insulinoma

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07808879
Acronym: HBED-CC-PEG6-E
Study type: INTERVENTIONAL
Masking: NONE
Status: RECRUITING
Enrollment: 20
Start: 2026-10-01
Primary completion: 2027-08-31
Lead sponsor: Peking Union Medical College Hospital
Conditions: Insulinoma
Interventions: DIAGNOSTIC_TEST:[68Ga]Ga-HBED-CC-PEG6-exendin-4 PET/CT; DIAGNOSTIC_TEST:[68Ga]Ga-HBED-CC-exendin-4 PET/CT
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER_GRANT:2025-PUMCH-D-003

Registered primary outcomes

Diagnostic performance comparison between two GLP-1R PET tracers for insulinoma localization [Up to 2 months after subjects complete both PET/CT scans and obtain pathological biopsy/surgical results]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.